J

Joinn Laboratories China Co Ltd
SSE:603127

Watchlist Manager
Joinn Laboratories China Co Ltd
SSE:603127
Watchlist
Price: 17.68 CNY -6.31% Market Closed
Market Cap: 11.1B CNY
Have any thoughts about
Joinn Laboratories China Co Ltd?
Write Note

Joinn Laboratories China Co Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Joinn Laboratories China Co Ltd
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
J
Joinn Laboratories China Co Ltd
SSE:603127
Accounts Payable
ÂĄ64.6m
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Accounts Payable
ÂĄ2B
CAGR 3-Years
15%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Accounts Payable
ÂĄ503m
CAGR 3-Years
23%
CAGR 5-Years
33%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Accounts Payable
ÂĄ3.1B
CAGR 3-Years
79%
CAGR 5-Years
65%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Accounts Payable
ÂĄ227.1m
CAGR 3-Years
22%
CAGR 5-Years
46%
CAGR 10-Years
31%
W
WuXi XDC Cayman Inc
HKEX:2268
Accounts Payable
ÂĄ620.5m
CAGR 3-Years
417%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Joinn Laboratories China Co Ltd
Glance View

Market Cap
11.1B CNY
Industry
Life Sciences Tools & Services

Joinn Laboratories China Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Beijing, Beijing and currently employs 2,140 full-time employees. The company went IPO on 2017-08-25. Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The firm conducts its businesses both in the domestic market and overseas markets.

Intrinsic Value
17.6 CNY
Fairly Valued
Intrinsic Value
Price
J

See Also

What is Joinn Laboratories China Co Ltd's Accounts Payable?
Accounts Payable
64.6m CNY

Based on the financial report for Jun 30, 2024, Joinn Laboratories China Co Ltd's Accounts Payable amounts to 64.6m CNY.

What is Joinn Laboratories China Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
10%

Over the last year, the Accounts Payable growth was 31%. The average annual Accounts Payable growth rates for Joinn Laboratories China Co Ltd have been 8% over the past three years , 10% over the past five years .

Back to Top